Filing Details

Accession Number:
0001601485-21-000023
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-18 16:04:40
Reporting Period:
2021-05-14
Accepted Time:
2021-05-18 16:04:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1601485 Angion Biomedica Corp. ANGN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1568249 J Jennifer Rhodes C/O Angion Biomedica Corp.
51 Charles Lindbergh Blvd.
Uniondale NY 11553
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-05-14 440 $13.92 33,447 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") granted by the Issuer.